Statistics

Total Visits

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial117

File Visits

Downloads
7415-31389.pdf51

Select a period of time:

Number of views in the range

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial40

Number of downloads in the range

Downloads
7415-31389.pdf24

Views

Views
December 20250
January 202610
February 20260
March 20268
April 20267
May 20263
June 202612
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • December 2025
    5
  • January 2026
    0
  • February 2026
    0
  • March 2026
    1
  • April 2026
    3
  • May 2026
    5
  • June 2026
    10
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States23
Colombia2
Argentina2
Chile1
China1
Cyprus1
Ecuador1
Spain1
France1
Guyana1
 

Top countries by downloads

Downloads
United States5
Colombia2
Argentina1
China1
 

Top cities views

Views
San Jose10
Council Bluffs4
Los Angeles2
Adıyaman1
Bogotá1
Concepción1
Córdoba1
Dundalk1
Georgetown1
Groningen1
 

Top cities by downloads

Downloads
Bogotá2
Groningen2
Los Angeles1